Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy in patients with extensive-stage small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials

OBJECTIVE: Many clinical trials of immune checkpoint inhibitors (ICIs) in combination with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC) have been initiated, but the conclusions of these trials are not identical. This meta-analysis aimed to comprehensiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chunlan, Tian, Peng, Zhong, Jiangshan, Fan, Xianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154633/
https://www.ncbi.nlm.nih.gov/pubmed/37152041
http://dx.doi.org/10.3389/fonc.2023.1151769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154633/
https://www.ncbi.nlm.nih.gov/pubmed/37152041
http://dx.doi.org/10.3389/fonc.2023.1151769

Ejemplares similares